<DOC>
	<DOC>NCT01677065</DOC>
	<brief_summary>To determine whether the bioavailability of the controlled-release test formulation is at least as high as that for the commercial reference drug.</brief_summary>
	<brief_title>A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers</brief_title>
	<detailed_description>Serial sampling of venous blood</detailed_description>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>healthy volunteers, greater than 50 kg, able and willing to sign informed consent Evidence of significant illness, condition affecting drug absorption, history of sleep apnea, and allergy to opioid drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Oxycodone</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>